Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Seda Tural Önür (Istanbul, Turkey), Seda Tural Onur, Sinem Sokucu, Levent Dalar, Kaan Kara, Songul Buyukkale, Sedat Altin. Malignant mesothelioma, are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio prognostic indicator parameters as reliable?. Eur Respir J 2015; 46: Suppl. 59, 4324

Member's Comments

No comment yet.

Related content which might interest you: Exploring the neutrophil/lymphocyte and platelet/lymphocyte ratios as biomarkers for lung cancer development Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 The prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with non-small cell lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker? Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Prognostic value of haematological markers such as neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in small cell lung cancer. Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Pulmonary originated sepsis: Can N/L ratio be used as follow-up marker? Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism Year: 2016 Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer? Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Evaluating the utility of mesothelin in diagnosing mesothelioma Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Changes in neutrophil-lymphocyte and platelet-lymphocyte ratios and clinical outcomes in idiopathic pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 Potential role of total antioxidant status ratio in differential diagnosis of pleural effusion Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases Year: 2013 Prognostic value of neutrophil-to-lymphocyte ratio in hospitalized patients with COVID-19 Source: Virtual Congress 2021 – COVID - 19 Year: 2021 Neutrophil to lymphocyte ratio (NLR) as a predictor of poor prognosis in advanced non-small cell lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Evaluation of pleural fluid total protein, albumin, globulin levels and albumin/globulin ratios in the differential diagnosis of pleural effusions Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 Is YKL-40 a prognostic marker in sarcoidosis? Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 BNP can be an all-cause mortality predictor in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 The protein DJ-1 in malignant pleural effusions due to lung cancer: Levels and correlations with oxidative stress biomarkers Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 An elevated neutrophil lymphocyte ratio is a poor prognostic marker in all categories of pleural effusions Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Predictive value of pro-inflammatory cytokine and pro-angiogenic factor in differentiating malignant from benign exudative effusion Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Is comorbidity a good prognostic factor for malignant pleural mesothelioma? Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Thymic tumours: update on classification and prognostic factors Source: Annual Congress 2012 - Diagnosis and management of thymic malignancies: an update Year: 2012 Neutrophil/lymphocyte ratio as a prognostic marker for curative-intent surgery in non-small cell lung cancer Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015